EVALUATION OF COVID-19 VACCINES IN PRIMARY PREVENTION AGAINST INFECTIONS AND REDUCTION IN SEVERITY OF ILLNESS FOLLOWING THE OUTBREAK OF SARS-COV-2 OMICRON VARIANT IN SHANGHAI

被引：0
|
作者：
Yang, D. [1 ]
Weng, H. [2 ]
Song, Y. [1 ]
Li, J. [3 ]
Lu, X. [3 ]
Yang, W. [2 ]
Chen, Z. [4 ]
Xuan, J. [3 ]
Bai, C. [1 ]
Wang, Y. [5 ]
机构：
[1] Fudan Univ, Dept Pulm & Crit Care Med, Zhongshan Hosp, Shanghai, Peoples R China
[2] Suvalue Healthcare Sci Co Ltd, Shanghai, Peoples R China
[3] Shanghai Centennial Sci Co Ltd, Shanghai, Peoples R China
[4] Guangzhou Med Univ, Dept Clin Res Management Off, Affiliated Hosp 3, Guangzhou, Peoples R China
[5] Army Med Univ, Inst Surg Res, Daping Hosp,Wound Trauma Med Ctr, State Key Lab Trauma Burns & Combined Injury, Chongqing, Peoples R China
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EPH100
引用
收藏
页码：S182 / S182
页数：1
相关论文
共 50 条
  • [31] Cytomegalovirus-vectored COVID-19 vaccines elicit neutralizing antibodies against the SARS-CoV-2 Omicron variant (BA.2) in mice
    Liu, Jian
    Jaijyan, Dabbu Kumar
    Chen, Yanling
    Feng, Changcan
    Yang, Shaomin
    Xu, Zhenglong
    Zhan, Nichun
    Hong, Congming
    Li, Shuxuan
    Cheng, Tong
    Zhu, Hua
    MICROBIOLOGY SPECTRUM, 2023,
  • [32] Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network
    Tartof, Sara Y.
    Xie, Fagen
    Yadav, Ruchi J.
    Wernli, Karen J.
    Martin, Emily T.
    Belongia, Edward A.
    Gaglani, Manjusha
    Zimmerman, Richard K.
    Talbot, H. Keipp
    Thornburg, Natalie
    Flannery, Brendan
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2023, 17 (05)
  • [33] Effectiveness of Inactivated COVID-19 Vaccines against COVID-19 Caused by the SARS-CoV-2 Delta and Omicron Variants: A Retrospective Cohort Study
    Hua, Qiaoli
    Zheng, Danwen
    Yu, Bo
    Tan, Xinghua
    Chen, Qiumin
    Wang, Longde
    Zhang, Jing
    Liu, Yuntao
    Weng, Heng
    Cai, Yihang
    Xu, Xiaohua
    Feng, Bing
    Zheng, Guangjuan
    Ding, Banghan
    Guo, Jianwen
    Zhang, Zhongde
    VACCINES, 2022, 10 (10)
  • [34] An Overview of Vaccines against SARS-CoV-2 in the COVID-19 Pandemic Era
    Pascual-Iglesias, Alejandro
    Canton, Javier
    Ortega-Prieto, Ana Maria
    Jimenez-Guardeno, Jose M.
    Regla-Nava, Jose Angel
    PATHOGENS, 2021, 10 (08):
  • [35] Are the COVID-19's vaccines efficient on the most dangerous variant of SARS-CoV-2?
    Davoodi, Poorya
    Hashemi, Atousa
    CLINICAL AND EXPERIMENTAL VACCINE RESEARCH, 2021, 10 (03) : 301 - 303
  • [36] Long COVID in Children and Youth Following Omicron Variant SARS-CoV-2
    不详
    JOURNAL OF PEDIATRICS, 2023, 259
  • [37] SARS-CoV-2 reinfection and COVID-19 severity
    Nguyen, Nhu Ngoc
    Houhamdi, Linda
    Hoang, Van Thuan
    Delerce, Jeremy
    Delorme, Lea
    Colson, Philippe
    Brouqui, Philippe
    Fournier, Pierre-Edouard
    Raoult, Didier
    Gautret, Philippe
    EMERGING MICROBES & INFECTIONS, 2022, 11 (01) : 894 - 901
  • [38] Illness Characteristics of COVID-19 in Children Infected with the SARS-CoV-2 Delta Variant
    Molteni, Erika
    Sudre, Carole H.
    Canas, Liane S.
    Bhopal, Sunil S.
    Hughes, Robert C.
    Chen, Liyuan
    Deng, Jie
    Murray, Benjamin
    Kerfoot, Eric
    Antonelli, Michela
    Graham, Mark
    Klaser, Kerstin
    May, Anna
    Hu, Christina
    Pujol, Joan Capdevila
    Wolf, Jonathan
    Hammers, Alexander
    Spector, Tim D.
    Ourselin, Sebastien
    Modat, Marc
    Steves, Claire J.
    Absoud, Michael
    Duncan, Emma L.
    CHILDREN-BASEL, 2022, 9 (05):
  • [39] Reduced neutralizing antibody potency of COVID-19 convalescent vaccinated plasma against SARS-CoV-2 Omicron variant
    Gallian, Pierre
    Amroun, Abdennour
    Laperche, Syria
    Le Cam, Sophie
    Brisbarre, Nadege
    Malard, Lucile
    Nurtop, Elif
    Isnard, Christine
    Richard, Pascale
    Morel, Pascal
    Tiberghien, Pierre
    de Lamballerie, Xavier
    VOX SANGUINIS, 2022, 117 (07) : 971 - 975
  • [40] Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study
    Gram, Mie Agermose
    Emborg, Hanne-Dorthe
    Schelde, Astrid Blicher
    Friis, Nikolaj Ulrik
    Nielsen, Katrine Finderup
    Moustsen-Helms, Ida Rask
    Legarth, Rebecca
    Lam, Janni Uyen Hoa
    Chaine, Manon
    Malik, Aisha Zahoor
    Rasmussen, Morten
    Fonager, Jannik
    Sieber, Raphael Niklaus
    Stegger, Marc
    Ethelberg, Steen
    Valentiner-Branth, Palle
    Hansen, Christian Holm
    PLOS MEDICINE, 2022, 19 (09)
12345